These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6409476)

  • 1. Determination of the second component of complement (C2) by electroimmunoassay in sera from patients with systemic lupus erythematosus.
    Ueda A; Kusaba T; Yanase T
    Clin Exp Immunol; 1983 Jul; 53(1):217-24. PubMed ID: 6409476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP; Cao VV; Fehér J; Gergely P
    Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K; Schur PH; Ruddy S
    Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.
    Harkiss GD; Hazleman BL; Brown DL
    J Clin Lab Immunol; 1979 Nov; 2(4):275-83. PubMed ID: 537024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Components of the classical complement pathway in systemic lupus erythematosus].
    Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
    Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.
    Arroyave CM; Wilson MR; Tan EM
    J Immunol; 1976 Mar; 116(3):821-6. PubMed ID: 815434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the alternative complement pathway in systemic lupus erythematosus.
    Wilson MR; Arroyave CM; Nakamura RM; Vaughan JH; Tan EM
    Clin Exp Immunol; 1976 Oct; 26(1):11-20. PubMed ID: 826360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticardiolipin and complement activation: relation to clinical symptoms.
    Norberg R; Nived O; Sturfelt G; Unander M; Arfors L
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():149-53. PubMed ID: 3612644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtotal C4 deficiency and SLE-like disease.
    Irestedt M; Svensson A; Månsson T
    Acta Derm Venereol; 1986; 66(1):67-70. PubMed ID: 2424221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
    Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    Clin Exp Immunol; 1974 Apr; 16(4):575-81. PubMed ID: 4219766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complement system in disseminated lupus erythematosus].
    Vasquez JJ; Fontan G; Gil A; Barbado J; Alvarez I; Ojeda JA
    Rev Rhum Mal Osteoartic; 1977 Dec; 44(12):725-31. PubMed ID: 76330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited deficiency of the second component of complement. Rheumatic disease associations.
    Glass D; Raum D; Gibson D; Stillman JS; Schur PH
    J Clin Invest; 1976 Oct; 58(4):853-61. PubMed ID: 965492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of complement measurements in the assessment of lupus activity.
    Milis L; Timmermans V; Morris CA; Pussell BA; Charlesworth JA
    Aust N Z J Med; 1992 Aug; 22(4):338-44. PubMed ID: 1445021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.